| 000 | 01714 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516105918.0 | ||
| 264 | 0 | _c20130405 | |
| 008 | 201304s 0 0 eng d | ||
| 022 | _a1460-2091 | ||
| 024 | 7 |
_a10.1093/jac/dks333 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChadwick, D | |
| 245 | 0 | 0 |
_aOutcomes of starting first-line antiretroviral therapy in hepatitis B virus/HIV-coinfected patients in Ghana. _h[electronic resource] |
| 260 |
_bThe Journal of antimicrobial chemotherapy _cDec 2012 |
||
| 300 |
_a2939-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Retroviral Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntiretroviral Therapy, Highly Active _xmethods |
| 650 | 0 | 4 | _aBody Mass Index |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 |
_aCoinfection _xdrug therapy |
| 650 | 0 | 4 |
_aDNA, Viral _xblood |
| 650 | 0 | 4 | _aDrug Resistance, Viral |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGhana |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 |
_aHepatitis B Surface Antigens _xblood |
| 650 | 0 | 4 |
_aHepatitis B, Chronic _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aTransaminases _xblood |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aAnkcorn, M | |
| 700 | 1 | _aSarfo, F | |
| 700 | 1 | _aPhillips, R | |
| 700 | 1 | _aFox, Z | |
| 700 | 1 | _aGarcia, A | |
| 700 | 1 | _aAppiah, L | |
| 700 | 1 | _aBedu-Addo, G | |
| 700 | 1 | _aGeretti, A M | |
| 773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 67 _gno. 12 _gp. 2939-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/dks333 _zAvailable from publisher's website |
| 999 |
_c22045864 _d22045864 |
||